Liam is the lead on a number of Poolbeg Pharma’s programmes. Liam was one of Poolbeg’s first employees, having previously worked for the CRO, hVIVO, conducting human challenge trials. He leads the POLB 001 programme for the prevention of cancer immunotherapy induced cytokine release syndrome and also oversees Poolbeg’s AI programs in infectious diseases. Liam is an advisor on licencing opportunities, and has particular interests in immunomodulatory therapies, unmet need in supportive therapies, and clinical development.
Liam has a PhD in Translational Cancer Research from University College Cork, having previously being trained as a Immunologist at Trinity College Dublin (BSc and MSc).